M0944035
Carboxyatractylosidetripotassiumsalt , Analysis of the control products, ≥98% , 77228-71-8
| Pack Size | Price | Stock | Quantity |
| 20mg | RMB1458.40 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Density | 1.58±0.1 g/cm3(Predicted) |
| storage temp. | -20°C |
| solubility | H2O: ≥10mg/mL |
| pka | -3?+-.0.18(Predicted) |
| form | solid |
| color | white |
| biological source | Xanthium sibiricum |
| optical activity | [α]/D -34 to -48°, c =0.5 in water |
| Water Solubility | H2O: ≥10mg/mL |
Description and Uses
Carboxyatractyloside potassium salt has been used as an activator of Ca2+-induced mPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) opening. It has also been used as a adenine nucleotide translocator (ANT) inhibitor to study the inhibition of oxidative phosphorylation in intact T98G glioma cells.
Safety
| Symbol(GHS) |  GHS06 |
| Signal word | Danger |
| Hazard statements | H301+H311+H331 |
| Precautionary statements | P261-P264-P280-P301+P310-P302+P352+P312-P304+P340+P311 |
| Hazard Codes | T |
| Risk Statements | 23/24/25 |
| Safety Statements | 36/37-45 |
| RIDADR | UN 2811 6.1 / PGI |
| WGK Germany | 3 |
RELATED PRODUCTS
![(2S,4aS,6aR,7S,9R,11aS,11bS)-7-Hydroxy-2-(((2R,3R,4R,5R,6R)-6-(hydroxymethyl)-3-((3-methylbutanoyl)oxy)-4,5-bis(sulfooxy)tetrahydro-2H-pyran-2-yl)oxy)-11b-methyl-8-methylenedodecahydro-6a,9-methanocyclohepta[a]naphthalene-4,4(4aH)-dicarboxylicaciddipotassiumsalt](https://img.chemicalbook.com/CAS/GIF/33286-30-5.gif)
(2S,4aS,6aR,7S,9R,11aS,11bS)-7-Hydroxy-2-(((2R,3R,4R,5R,6R)-6-(hydroxymethyl)-3-((3-methylbutanoyl)oxy)-4,5-bis(sulfooxy)tetrahydro-2H-pyran-2-yl)oxy)-11b-methyl-8-methylenedodecahydro-6a,9-methanocyclohepta[a]naphthalene-4,4(4aH)-dicarboxylicaciddipotassiumsalt
33286-30-5
33286-30-5
Madecassicacid
18449-41-7
18449-41-7
TerrestrosinK
193605-07-1
193605-07-1
1,3,5-Tricaffeoylquinicacid
1073897-80-9
1073897-80-9
Pachymicacid
29070-92-6
29070-92-6